60 Degrees Pharmaceuticals Licenses Patent to Produce Australian Chestnut Extract

MT Newswires Live06-11

60 Degrees Pharmaceuticals (SXTP) said Thursday it signed a patent licensing agreement with Florida State University to develop large-scale production methods for Australian chestnut extract, a substance derived from the seeds of the Australian chestnut tree.

The company said the extract contains castanospermine, a naturally occurring compound that studies suggest may affect how the body processes carbohydrates and regulates blood sugar levels.

The company said the US Food and Drug Administration has provided feedback on its filing seeking approval to market the extract as a dietary supplement ingredient.

The FDA and the company are scheduled to meet on July 1 to discuss additional safety information needed for the application, the company said, adding that it plans to submit a revised application to the agency following the meeting.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2642923284?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-11 20:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2642923284","market":"fut","top_or_hot":-1,"title":"60 Degrees Pharmaceuticals Licenses Patent to Produce Australian Chestnut Extract","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/SXTPW\">60 Degrees</a> Pharmaceuticals (SXTP) said Thursday it signed a patent licensing agreement with Florida State University to develop large-scale production methods for Australian chestnut extract, a substance derived from the seeds of the Australian chestnut tree.</p><p>The company said the extract contains castanospermine, a naturally occurring compound that studies suggest may affect how the body processes carbohydrates and regulates blood sugar levels.</p><p>The company said the US Food and Drug Administration has provided feedback on its filing seeking approval to market the extract as a dietary supplement ingredient.</p><p>The FDA and the company are scheduled to meet on July 1 to discuss additional safety information needed for the application, the company said, adding that it plans to submit a revised application to the agency following the meeting.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>60 Degrees Pharmaceuticals Licenses Patent to Produce Australian Chestnut Extract</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n60 Degrees Pharmaceuticals Licenses Patent to Produce Australian Chestnut Extract\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-06-11 20:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/SXTPW\">60 Degrees</a> Pharmaceuticals (SXTP) said Thursday it signed a patent licensing agreement with Florida State University to develop large-scale production methods for Australian chestnut extract, a substance derived from the seeds of the Australian chestnut tree.</p><p>The company said the extract contains castanospermine, a naturally occurring compound that studies suggest may affect how the body processes carbohydrates and regulates blood sugar levels.</p><p>The company said the US Food and Drug Administration has provided feedback on its filing seeking approval to market the extract as a dietary supplement ingredient.</p><p>The FDA and the company are scheduled to meet on July 1 to discuss additional safety information needed for the application, the company said, adding that it plans to submit a revised application to the agency following the meeting.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"STW.AU","symbol_name":"SPDR® S&P/ASX 200 ETF","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2642923284","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2642923284","pubTimestamp":1781181200,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"60 Degrees Pharmaceuticals  said Thursday it signed a patent licensing agreement with Florida State University to develop large-scale production methods for Australian chestnut extract, a substance derived from the seeds of the Australian chestnut tree.The company said the extract contains castanospermine, a naturally occurring compound that studies suggest may affect how the body processes carbohydrates and regulates blood sugar levels.The company said the US Food and Drug Administration has provided feedback on its filing seeking approval to market the extract as a dietary supplement ingredient.The FDA and the company are scheduled to meet on July 1 to discuss additional safety information needed for the application, the company said, adding that it plans to submit a revised application to the agency following the meeting.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"STW.AU":"SPDR® S&P/ASX 200 ETF","BK4007":"制药","OZR.AU":"SPDR S&P/ASX 200 RESOURCES F","XAO.AU":"标普/澳交所 普通股指数","XJO.AU":"标普/澳交所 200指数","XKO.AU":"标普/澳交所 300指数","IMLC.AU":"INV MUTUAL CONC AUS SHAR ETF","SLF.AU":"SPDR S&P/ASX 200 LISTED PROP","IIGF.AU":"Intelligent Investor Australian Equity Growth Fund (Managed Fund)","QFN.AU":"BetaShares Australian Fincls Sect ETF","QRE.AU":"BetaShares Australian Res Sect ETF","EIGA.AU":"EINVEST INCOME GENERATOR FD","SXTP":"60 degrees pharmaceuticals, Inc.","IISV.AU":"INTELL INV SELVAL SHR FD MF","ZYAU.AU":"Etfs S&p/asx 300 High Yield Plus Etf","BBOZ.AU":"BETASHARES AUSTRALIAN STRONG BEAR (HEDGE FUND)","GEAR.AU":"BETASHARES GEARED AUS EQTY F","VAP.AU":"VANGUARD AU PROP SEC IDX ETF","GIVE.AU":"PERPETUAL ESG AU SHR EQMF","DACE.AU":"DIMENSIONAL AUST CORE EQ","VAS.AU":"VANGUARD AUST SHARES IDX ETF","IOZ.AU":"iShares Core S&P/ASX 200","OZF.AU":"SPDR S&P/ASX 200 FINANCIALS","E200.AU":"SPDR S&P/ASX 200 ESG FUND","BEAR.AU":"BETASHARES AUS EQ BEAR HF"},"translate_title":"60度制药许可专利生产澳大利亚板栗提取物","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OZF.AU":0.6,"IOZ.AU":0.6,"QFN.AU":0.6,"OZR.AU":0.6,"XAO.AU":1.5,"ZYAU.AU":0.6,"XKO.AU":1.5,"XJO.AU":1.5,"GIVE.AU":0.6,"GEAR.AU":0.6,"VAS.AU":0.6,"IMLC.AU":0.6,"VAP.AU":0.6,"BBOZ.AU":0.6,"DACE.AU":0.6,"BEAR.AU":0.6,"QRE.AU":0.6,"SXTP":1,"IISV.AU":0.6,"EIGA.AU":0.6,"STW.AU":0.6,"SLF.AU":0.6,"E200.AU":0.6,"IIGF.AU":0.6},"content_text":"60 Degrees Pharmaceuticals (SXTP) said Thursday it signed a patent licensing agreement with Florida State University to develop large-scale production methods for Australian chestnut extract, a substance derived from the seeds of the Australian chestnut tree.The company said the extract contains castanospermine, a naturally occurring compound that studies suggest may affect how the body processes carbohydrates and regulates blood sugar levels.The company said the US Food and Drug Administration has provided feedback on its filing seeking approval to market the extract as a dietary supplement ingredient.The FDA and the company are scheduled to meet on July 1 to discuss additional safety information needed for the application, the company said, adding that it plans to submit a revised application to the agency following the meeting.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2642923284","isCrawlerRequest":true}